Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for emergence agitation in elderly patients undergoing abdominal cancer surgery
PACTR202502657476266Phase 1Not yet recruiting
- Sponsor
- Ehab Mohamed Ahmed Mokbel
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of dexmedetomidine in Emergence agitation (EA) (2 arms), sponsored by Ehab Mohamed Ahmed Mokbel. Primary endpoint: Level of agitation during emergence. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on PACTR202502657476266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502657476266.